Table 2 characteristics of treatment
Radiotherapy | Number (%) | |
|---|---|---|
146 (88) | ||
RT/clinical stage | ||
I | 17 (10.2) | |
II | 58 (34,9) | |
III | 45 (27,1) | |
IV | 26 (15,6) | |
RT dose | Median (Gy) | Range (Gy) |
21 | 10–40 | |
RT/level dose Gy | Number (%) | |
10 – 20 Gy | 2 (1.3) | |
21 – 30 Gy | 143 (98) | |
31 – 40 Gy | 1 (0.7) | |
RT field | Number (%) | |
Involved field | 72 (43,3) | |
Mantle field | 58 (34,9) | |
Infradiafragmatic field | 9 (5,4) | |
Total nodal irradiation | 7 (4,2) | |
Chemotherapy | Number (%) | |
ABVD | 65 (39) | |
VEEP | 22 (13) | |
MOPP | 22 (13) | |
OPPA | 33 (22) | |
OPPA +ABVD | 22 (13) |